Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Scientific Data|November 19, 2025
A multimodal physiological dataset for non-invasive blood glucose estimationWaris Quamer, Mu-Ruei Tseng, Kathan Vyas, et al.
Diabetes Technology & Therapeutics|October 31, 2013
Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemiaDaniel J DeSalvo, Patrick Keith-Hynes, Thomas Peyser, et al.
Pediatric Diabetes|April 30, 2025
Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY TrialLaurel H Messer, Colleen Bauza, Kellee M Miller, et al.
Diabetes, Obesity & Metabolism|July 25, 2018
Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registrySarah K Lyons, Claire T Boyle, Daniel J DeSalvo, et al.
Diabetes Technology & Therapeutics|August 10, 2022
Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement CollaborativeDaniel J DeSalvo, Stefanie Lanzinger, Nudrat Noor, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|June 7, 2022
Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With DiabetesCari Berget, Jennifer L Sherr, Daniel J DeSalvo, et al.
Diabetes Research and Clinical Practice|May 2, 2025
SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetesSarah S Jaser, Tamim A Hamdan, Marisa E Hilliard, et al.
Pediatric Diabetes|June 21, 2018
Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV InitiativeDaniel J DeSalvo, Kellee M Miller, Julia M Hermann, et al.
Diabetes Care|February 26, 2025
Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic OutcomesElizabeth A Mann, Saketh Rompicherla, Brian Miyazaki, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 DiabetesGregory P Forlenza, Daniel J DeSalvo, Grazia Aleppo, et al.
Pageof 7